Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

about

Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1

P2860

Q38874116-320FF4CB-2D0A-4B3F-B653-C2B8506E07EF Q42058494-6BC771A1-D154-498D-AD53-FDEBC9AB11D2 Q42605451-A1F6A1B3-14E8-497C-B0F4-F3F4848BE983

P2860

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

Item

http://www.wikidata.org/entity/Q42675929

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@en

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@nl

type

Item

label

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@en

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@nl

prefLabel

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@en

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@nl

P1476

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

@en

P2093

Joshua M Hare

http://www.w3.org/2001/XMLSchema#string

Konstantinos E Hatzistergos

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian heart renewal by pre-existing cardiomyocytes

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Adult cardiac stem cells are multipotent and support myocardial regeneration

Stem cells and niches: mechanisms that promote stem cell maintenance throughout life

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

Rapid fusion between mesenchymal stem cells and cardiomyocytes yields electrically active, non-contractile hybrid cells

Evidence that human cardiac myocytes divide after myocardial infarction.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

c-kit+ cells minimally contribute cardiomyocytes to the heart

Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.

P304

659-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/CIRCRESAHA.115.307346

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26405181

http://www.w3.org/2001/XMLSchema#string

P932

4705032

http://www.w3.org/2001/XMLSchema#string

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

about

P2860

P2860

Cell Therapy: Targeting Endogenous Repair Versus Remuscularization

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932